Article

Importance of Breast Cancer Screening Highlighted on National Mammography Day

Early detection is crucial for breast cancer survival.

Each year, the third Friday of Breast Cancer Awareness Month is dedicated to raising awareness for the importance of mammograms. National Mammography Day, which was first introduced in 1993 by President Bill Clinton, falls on October 20 this year.

Women’s health advocates recommend that women observe this day by scheduling their yearly mammograms.

The goal of National Mammography Day is to increase awareness about the importance of breast cancer screenings, according to the FDA’s Office of Women’s Health.

“National Mammography Day puts the focus on breast cancer screening and it’s important for women to adhere to the guidelines that have been put forth,” Arnold M. Baskies, MD, FACS, chairman of the National Board of Directors for the American Cancer Society (ACS), told Specialty Pharmacy Times.

Mammograms are currently the gold standard for breast cancer screening. While other methods can detect abnormalities, mammograms can discover lumps that may be too small to see or feel, according to the FDA.

National Mammography Day aims to reinforce the notion that early detection is the best defense against the disease. Early detection is known to result in better patient outcomes due to prompt treatment and limited time for metastasis.

“The earlier you detect breast cancer, the better your chance of survival. Even those with no family history of the disease can be affected,” Beth Anne Holl, director of Educational Outreach at the American Breast Cancer Foundation told SPT. “Breast cancer affects all ages, races, and genders. This is why it is so incredibly important to be vigilant to your body and to get regular screenings for breast cancer.”

Current guidelines indicate that women of average risk aged 40 to 44 could begin annual screenings, while women aged 45 to 54 are advised to get an annual mammogram, according to the ACS. Women over age 55 may choose to continue yearly mammograms or receive them every other year.

“The most accurate scientific guidelines available are those that have been put together within the last 3 years by the American Cancer Society,” Dr Baskies said. “They are evidence-based and make the most sense in terms of detection and treatment.”

Adhering to these guidelines and receiving regular mammograms can save lives and help reduce breast cancer-related deaths, especially among women aged 40 to 70, according to the FDA.

Breast cancer can affect nearly anyone, including men. Current estimates show that 1 in 8 women in the United States will be diagnosed with breast cancer during their lifetime.

“Early detection is the key to surviving the disease, and we encourage everyone to do regular self-checks and to be proactive in getting screened for breast cancer the minute something looks off. It could save your life,” Holl said.

Some women may face a higher risk of breast cancer for various reasons, including when menstruation started, having children, family history, and genetics, Dr Baskies said.

The exact cause of breast cancer is unknown for most individuals; however, inherited genes—such as BCRA 1/2—and lifestyle factors—such as exercise and food—are known to influence the risk of breast cancer.

While there is no uniform way that all women can reduce their risk of breast cancer, there are some relatively simple steps that can be taken.

“In terms of decreasing risk, we know that weight gain and obesity are related to higher risk of breast cancer,” Dr Baskies told SPT. “We know that alcohol consumption increases the risk and there’s some data that indicates smoking may increase the risk for breast cancer. All of those things have to be taken into consideration.”

In general, eating nutritious foods, engaging in physical activity, and living a healthy life may reduce the risk of breast cancer for many women.

It is crucial for women to understand their risk of developing breast cancer and the importance of screening, especially during Breast Cancer Awareness Month.

Specialty pharmacies are also a critical resource in terms of screening and can provide patients with the support and care they need to beat breast cancer.

“Mammograms are a critical screening tool for breast cancer, but they are also important for patients after they have received treatment. Specialty pharmacies can be a tremendous resource in ensuring connected care," said Kelly Ratliff, president of US Bioservices, a part of AmerisourceBergen. "For example, we work collaboratively with physicians, insurance companies, and drug manufacturers so that patients have the best experience, and this can include reminders to consult with a patient’s physician about mammogram needs after treatment. Lastly, the key for us is also providing holistic care that goes beyond the medication journey, like providing 24 clinical support, in-home nursing services, and resources that can reduce the many barriers these women are facing, such as finances, transportation, family responsibilities, nutrition, or simple day-to-day activities.”

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards